JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Varonis to Present at Upcoming March Conferences
-
TrueCar Announces Upcoming March Conference Participation
-
JMP Securities Starts Newtek Business Services (NEWT) at Market Perform
-
Notable Analyst Rating Changes 2/23: (LH) (PENN) (CL) Upgraded; (BA) (RIG) (DGX) Downgraded
-
JMP Securities Starts Flex Pharma (FLKS) at Market Outperform
-
Notable Analyst Rating Changes 2/19: (COH) (VLO) (MWW) Upgraded; (I) (PCYC) (HUN) Downgraded
-
JMP Securities Starts TubeMogul, Inc (TUBE) at Market Outperform
-
JMP Securities Downgrades Vascular Biogenics Ltd (VBLT) to Market Perform
-
Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Triangle Capital Corporation Closes Overallotment Option in Connection With Public Offering of 6.375% Notes Due 2022 and Trading of Notes Begins on NYSE
-
Achillion Pharma (ACHN) 12M Offering Prices at $10.25/Share
-
JMP Securities Downgrades AOL, Inc. (AOL) to Market Perform
-
Nexvet Biopharma (NVET) Closes 4M Common IPO at $4/Share
-
Nexvet Biopharma Announces Closing of Initial Public Offering
-
Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
-
JMP Securities Starts Patriot National (PN) at Market Outperform
-
JMP Securities Downgrades Chesapeake Lodging Trust (CHSP) to Market Perform
-
Nexvet Biopharma (NVET) IPO Opens Down 9%
-
BIND Therapeutics (BIND) Prices 3.7M Offering at $5.75/Unit
-
JMP Securities Downgrades PartnerRe (PRE) to Market Perform
-
Ultragenyx Pharmaceutical (RARE) 3M Offering Prices at $54/Share
-
Intercept Pharma (ICPT) 1M Stock Offering Prices at $176/Share
-
Nexvet Biopharma plc Announces Pricing of Initial Public Offering
-
Intercept Pharmaceuticals Announces Pricing of Public Offering
-
BIND Therapeutics (BIND) to Offer Common Stock and Warrants
-
BIND Therapeutics (BIND) Announces Common Stock Offering
-
Senior Housing Properties Trust (SNH) Prices 27M Share Offering at $22.20/Share
-
JMP Securities Upgrades Myriad Genetics (MYGN) to Market Outperform
-
Ultragenyx Pharmaceutical (RARE) to Offer $125M in Common Stock
-
JMP Securities Downgrades Broadcom (BRCM) to Market Perform
-
JMP Securities Downgrades Align Technology (ALGN) to Market Perform
-
Notable Analyst Rating Changes 1/29: (CYOU) (BR) (RKT) Upgraded; (CAVM) (XEC) (MSFT) Downgraded
-
Flex Pharm (FLKS) IPO Opens Up 19%
-
Neovasc (NVCN) Increases Size of Stock Offering Due to Interest, 10.5M Prices at $7.19/Share
-
JMP Securities Downgrades Cavium Networks (CAVM) to Market Perform
-
Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Follow-on Public Offering of Common Stock
-
JMP Securities Downgrades RE/MAX Holdings (RMAX) to Market Underperform
-
JMP Securities Downgrades Qualys (QLYS) to Market Perform
-
Vitae Pharmaceuticals (VTAE) Prices 3M Common Follow-On at $11.90/Share
-
Vitae Pharmaceuticals Announces Pricing of Follow-on Public Offering of Common Stock
-
Zafgen (ZFGN) Prices Larger 3.94M Common Offering at $35/Share
-
Keryx Biopharma (KERX) Prices 9.17M Common Offering at $12/Share
-
Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock
-
JMP Securities Downgrades Forestar Group (FOR) to Market Perform
-
JMP Securities Starts Capitala Finance (CPTA) at Market Outperform
-
Alnylam Pharma (ALNY) Prices 4.74M Common Offering at $95/Share
-
Zafgen (ZFGN) to Offer 2.84M Common Shares
-
Notable Analyst Rating Changes 1/20: (BAC) (MU) (EXC) Upgraded; (ADM) (INTC) (YNDX) Downgraded
-
JMP Securities Downgrades M/I Homes (MHO) to Market Perform
-
JMP Securities Downgrades Hovnanian Enterprises (HOV) to Market Underperform

